Home › Forums › Valdig.eu website › Prophylaxis of SOS in patient with vascular liver disease › Reply To: Prophylaxis of SOS in patient with vascular liver disease
3 August 2021 at 22h38 #2799
Thanks for the follow-up.
UDCA as been shown as beneficial as a prophylaxis in BMT (Ruutu Biol Blood Marrow Transplant. 2014), although the hepatic endpoint was rather vague. But it does not harm. In Paris, UDCA is very widely given as a prophylaxis in BMT.